Salesforce (CRM) Q2 2027 Earnings Call Transcript

Salesforce reported Q2 revenue of $11.35B (+11% YoY) and Non-GAAP EPS of $5.90 (+103% YoY), alongside record free cash flow of $1.1B (+81% YoY). The company’s AI momentum was highlighted by Agentforce ARR exceeding $1.5B (+240% YoY) and AI & Data ARR nearing $3.9B (+210% YoY), with Agentic Work Units (AWUs) at 3.2B (+97% QoQ). Guidance was raised by $300M in constant currency to FY2027 revenue of $46.1B–$46.4B (11%–12% growth range), and Salesforce reiterated strong operating discipline (Q2 non-GAAP op margin 34.1%) while continuing a $25B accelerated share repurchase program, expecting to repurchase at least 14% of shares outstanding at an average $176/share.

Analysis

This is a platform-power story, not a one-quarter beat. The economic signal is that AI is increasing the value of the control plane: identity, data, workflow, and governance now matter more than the model layer, which supports CRM’s ability to pull spend from adjacent budgets rather than merely defend seats. That dynamic is quietly negative for point solutions and workflow vendors that lack a trusted data layer; NOW is the cleanest competitive read-through on the ITSM side, while INFA faces a longer-term threat if Salesforce turns data access into a bundled feature rather than a standalone purchase.

The near-term catalyst path is Dreamforce and the next two quarters of conversion data. The market will care less about headline ARR and more about whether pilot activity becomes durable paid usage, whether premium edition attachment stays high, and whether the consumption flywheel keeps refilling rather than plateauing. The buyback also matters mechanically: retiring a low-teens percentage of shares can cushion any multiple compression and amplify upside if management proves the AI monetization story is real.

Contrarian risk: the consensus may be too focused on the death-of-SaaS debate and not enough on pricing-quality risk. A lot of the guide raise is not purely organic, and the burden of proof is now on monetization, not adoption theater; if next-quarter renewal behavior or cRPO decelerates, the stock can de-rate fast because the market is paying for acceleration. The thesis is falsified if premium upgrade penetration stalls, net new AOV stops outgrowing AOV, or Dreamforce fails to produce measurable commercial conversions rather than feature demos.

Key Decisions for Investors

• Long CRM on pullbacks into Dreamforce; best expressed with a 12-18 month call spread such as Jan-2027 180/220 to capture buyback support plus monetization upside. Falsify if premium edition attachment or net new AOV re-acceleration stalls over the next two quarters.
• Pair trade: long CRM / short NOW for 1-3 months. Thesis is that agentic workflow expansion and ITSM adjacency should pressure ServiceNow budget share before NOW can prove a new AI revenue leg; cover if NOW reaccelerates renewal growth or CRM head-head conversions disappoint.
• Pair trade: long CRM / short INFA over 6-12 months. If Data 360 and zero-copy become the default enterprise data path, standalone integration spend is at risk of being bundled into CRM workflows; exit if INFA shows sustained cloud integration acceleration independent of Salesforce.
• Watchlist long NVDA as an indirect beneficiary of enterprise AI spend durability. This is not a direct read-through on model share, but if agentic usage keeps scaling, inference and enterprise compute demand stay firm; thesis weakens if CRM usage grows without corresponding cloud/compute intensity.